Michael Cannon is the Director of Health Policy Studies at the Cato Institute. We'll discuss President Trump's executive order that aims to reduce American (prescription) drug prices.
Michael F. Cannon | Cato Institute
Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients – The White House
Trump executive order gives drugmakers 30-day deadline to lower drug costs | AP News
Trump's drug price plan: Why it may not amount to much change
Trump drug price order puts new pressure on pharma
It was interesting to hear RFK Jr praise Trump for implementing a Bernie Sanders policy proposal. Is that really what a Republican president, even a populist like Trump, wants to hear?